Margaret Haney

Dr. Haney is internationally recognized for her expertise in cannabis and cannabinoids. Her current work focusses on (1) conducting placebo- controlled studies testing the efficacy of potential treatment medications for cannabis use disorder, and (2) testing the potential therapeutic effects of cannabis and its constituents for a range of indications, including appetite- enhancement and pain. Dr. Haney’s research has been continuously supported by the National Institute of Health since 1999. She is an Associate Editor for Cannabis and Cannabinoid Research and is an Advisory Editor for Psychopharmacology. Dr. Haney is a Fellow at the American College of Neuropsychopharmacology, and the recent past President of the College on Problems of Drug Dependence.